GSK plc Director Share Acquisitions Through Dividend Reinvestment Plan
GSK plc filed a Form 6-K reporting multiple share acquisitions by company directors and persons closely associated with them (PCAs) through the company's Share Reward Plan. The transactions occurred on April 9, 2026, and involved the reinvestment of dividends to purchase ordinary shares at a price of Β£21.3387 per share. Key executives including CEO Luke Miels (2 shares), President Europe Lynn Baxter (32 shares), Chief People Officer Diana Conrad (5 shares), and other senior leaders acquired shares. Additionally, PCAs of executives including Neil Falkingham (54 shares) and Iain Whyte (1,006 shares) also participated in the dividend reinvestment program. These transactions represent routine dividend reinvestment activities rather than discretionary purchases, indicating ongoing participation in the company's equity compensation programs.